Covered recipient · General Payments record
GINA M VOLPE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,633.90
- Reported across 564 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $460.77 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.01 | 11 |
| PFIZER INC. | $71.14 | 4 |
| Novo Nordisk AS | $58.08 | 4 |
| DEXCOM, INC. | $28.12 | 1 |
| Astellas Pharma US Inc | $27.47 | 2 |
| Ortho-Clinical Diagnostics, Inc. | $26.78 | 1 |
| Lilly USA, LLC | $23.59 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.02 | 1 |
| Seqirus USA Inc | $14.94 | 1 |
| Acerta Pharma LLC | $14.23 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.18 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291466 | CMS |
| ABBVIE INC. | $9.51 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291468 | CMS |
| ABBVIE INC. | $15.20 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291470 | CMS |
| ABBVIE INC. | $12.43 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291472 | CMS |
| ABBVIE INC. | $24.08 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291474 | CMS |
| ABBVIE INC. | $21.85 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291476 | CMS |
| ABBVIE INC. | $8.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291478 | CMS |
| ABBVIE INC. | $16.70 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291480 | CMS |
| ABBVIE INC. | $17.58 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291482 | CMS |
| ABBVIE INC. | $8.34 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291484 | CMS |
| ABBVIE INC. | $8.23 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106291486 | CMS |
| Astellas Pharma US Inc | $13.19 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369687 | CMS |
| Astellas Pharma US Inc | $14.28 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139355983 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.23 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104534981 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.39 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117988998 | CMS |
| Dexcom, Inc. | $28.12 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153301813 | CMS |
| Lilly USA, LLC | $23.59 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134978248 | CMS |
| Novo Nordisk Inc | $13.09 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907789 | CMS |
| Novo Nordisk Inc | $16.40 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097308965 | CMS |
| Novo Nordisk Inc | $15.00 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097742074 | CMS |
| Novo Nordisk Inc | $13.59 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096860034 | CMS |
| Ortho-Clinical Diagnostics, Inc. | $26.78 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154761212 | CMS |
| PFIZER INC. | $23.79 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131066768 | CMS |
| PFIZER INC. | $13.83 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131006859 | CMS |
| PFIZER INC. | $15.46 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132012128 | CMS |
| PFIZER INC. | $18.06 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131983155 | CMS |
| Seqirus USA Inc | $14.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125627716 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.02 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144595564 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.